Kyriazi Theo Melas - Feb 16, 2023 Form 4 Insider Report for Codiak BioSciences, Inc. (CDAKQ)

Role
Director
Signature
/s/ Yalonda Howze, Attorney-in-Fact for Theo Melas-Kyriazi
Stock symbol
CDAKQ
Transactions as of
Feb 16, 2023
Transactions value $
$0
Form type
4
Date filed
2/21/2023, 03:30 PM
Previous filing
Jun 21, 2022
Next filing
Jun 12, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDAKQ Common Stock Options Exercise +8.75K +132.58% 15.4K Feb 16, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDAKQ Restricted Stock Units Options Exercise $0 -8.75K -100% $0.00* 0 Feb 16, 2023 Common Stock 8.75K Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.
F2 Each RSU represents a contingent right to receive one share of common stock.
F3 On February 16, 2022, the reporting person was granted 8,750 RSUs, which vested in full on February 16, 2023.